<DOC>
	<DOCNO>NCT01897337</DOCNO>
	<brief_summary>PONV ( Postoperative nausea vomit ) one common complication general anesthesia . Female sex , history PONV , motion sickness , nonsmoker status , use volatile agent , duration anesthesia , opioid administration laparoscopic surgery know risk factor develop PONV . In consequence , patient undergo laparoscopic gynecologic surgery high risk develop PONV . Most patient use fentanyl base IV-PCA . And also cause PONV . So , prevent PONV patient use multimodal combination therapy . Aprepitant NK1 receptor antagonist.And use prevent chemotherapy induce nausea vomit . Many study use aprepitant prevent PONV progress . In study , investigate effect combine aprepitant ondansetron high-risk patient PONV .</brief_summary>
	<brief_title>The Effect Combining Aprepitant With Ondansetron High-risk Patients Postoperative Nausea Vomiting</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Patient undergo laparoscopic gynecologic surgery . Patient take fentanyl base IV PCA ASA class III allergy aprepitant take another antiemetic surgery decrease liver function psychological disease speak Korean take medicine interacts emend agree study</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>